CompletedNot Applicable

Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea

South Korea230 participantsStarted 2024-09-30

Plain-language summary

To observation that long term follow-up study of 'Immuncell-LC groups' and 'Non-treatment groups' in patient undergo curative resection (PEIT, RFA or Operation) for hepatocellular carcinoma in Korea

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients of participated in the(ClinicalTrials.gov Identifier:NCT00699816)clinical trial. Exclusion Criteria: * NA

What they're measuring

Recurrence-free Survival(RFS)

Timeframe: up to 9 years

Trial details

NCT IDNCT06620510

SponsorGC Cell Corporation

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-12-05

View on ClinicalTrials.gov More Hepatocellular Carcinoma trials